A Phase III Randomized Feasibility Study Comparing Stereotactic Body Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) For Patients With Spinal Metastases
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Clinical Trial Registration
Related Post
21 July, 2026
New TROG Scientific Committee Chair-Elect and members bring diverse experience
LATEST NEWS: 21 July 2026 The TROG Scientific Committee
16 July, 2026
TROG 08.03 RAVES sub-study sheds light on quality of life after post-prostatectomy radiotherapy
LATEST NEWS: 16 July 2026 Secondary analysis of data